Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Clinician's Roundtable

Health Policy: Weighing Treatment Effectiveness vs. Cost

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    The individual's healthcare in the last 12 months of life costs about 25% of total healthcare costs for that person's life. Should policy makers’ better control end-of-life costs? This is just one of many questions addressed in this segment about weighing the effectiveness of treatment vs. cost. Join us as host Dr. Bill Rutenberg interviews Senior Medical Economist of the Rand Corporation, Geoffrey Joyce PhD.

Recommended
Details
Presenters
Comments
  • Overview

    The individual's healthcare in the last 12 months of life costs about 25% of total healthcare costs for that person's life. Should policy makers’ better control end-of-life costs? This is just one of many questions addressed in this segment about weighing the effectiveness of treatment vs. cost. Join us as host Dr. Bill Rutenberg interviews Senior Medical Economist of the Rand Corporation, Geoffrey Joyce PhD.

Schedule2 Dec 2024